ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Pediatric"

  • 2020 American Transplant Congress

    Association of Congenital Anomalies of the Kidney and Urinary Tract with Urinary Tract Infection and Graft Rejection in Pediatric Kidney Transplant Recipients

    M. Bock, D. Han, A. Sikora, K. Mckinnon, S. Hecht, M. Chandran, V. Vemulakonda

    Children's Hospital Colorado, Denver, CO

    *Purpose: Congenital anomalies of the kidney and urinary tract (CAKUT) are a leading cause of pediatric end-stage renal disease (ESRD). Prior studies have shown an…
  • 2020 American Transplant Congress

    Yield and Utility of Surveillance Kidney Biopsies in Pediatric Kidney Transplant Recipients at Various Time Points Post-Transplant

    A. Landsberg1, M. Riazy2, T. Blydt-Hansen1

    1Nephrology, BC Children's Hospital, Vancouver, BC, Canada, 2Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, BC, Canada

    *Purpose: There lacks consensus regarding the appropriate timing of routine surveillance biopsies (SB) for pediatric kidney transplant recipients. We evaluated the yield of positive biopsy…
  • 2020 American Transplant Congress

    Antimicrobial Prophylaxis Post Antibody Mediated Rejection Treatment in Pediatric Kidney Transplant Recipients: Interim Report from the Paramour “PediAtric Renal AMr Outcomes” Study

    S. Solomon1, R. Garro2, N. Hayde3, A. Jain4, M. Kallash5, K. Twombley6, I. Ashoor7

    1Maria Fareri Children's Hospital, Valhalla, NY, 2Emory University, Atlanta, GA, 3The Children's Hospital at Montefiore, Bronx, NY, 4Children's Hospital of Michigan, Detroit, MI, 5Nationwide Children's Hospital, Columbus, OH, 6Medical University of South Carolina, Charleston, SC, 7LSU Health New Orleans, New Orleans, LA

    *Purpose: Universal guidelines do not exist for post antibody mediated rejection (AMR) treatment antimicrobial prophylaxis (ppx) in pediatric kidney transplant (KT) recipients. We sought to…
  • 2020 American Transplant Congress

    Pediatric Liver Transplantation for Metabolic Liver Diseases versus Biliary Atresia: Single Center Experience

    A. M. Elsabbagh, K. M. Khan, A. A. Amin, S. S. Kaufman, N. A. Yazigi, T. M. Fishbein

    MedStar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC

    *Purpose: The main indication for LT in children has been biliary atresia (BA). Recent advances in surgical management and the development of new immunosuppressants have…
  • 2020 American Transplant Congress

    The Impact of Non-Directed Anonymous Live Liver Donors on the Number of Children on the Waitlist at a Single Pediatric Liver Transplant Center

    D. Yoeli1, M. A. Adams1, M. E. Wachs1, S. S. Sundaram2, R. A. Choudhury1, K. D. Conzen1, J. R. Burton3, E. A. Pomfret1, W. E. Jackson3

    1Transplant Surgery, University of Colorado, Aurora, CO, 2Pediatric Hepatology, University of Colorado, Aurora, CO, 3Transplant Hepatology, University of Colorado, Aurora, CO

    *Purpose: Since the initiation of our living donor (LD) pediatric liver transplant program in November 2016, 10 non-directed anonymous donors have been approved and completed…
  • 2020 American Transplant Congress

    Significance of Pathology in Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients on 1 Year Outcomes: Interim Results of the Paramour “Pediatric Renal AMR Outcomes” Study

    I. Ashoor1, A. Jain2, R. Garro3, M. Kallash4, S. Soloman5, K. Twombley6

    1LSUHSC and Children's Hospital New Orleans, New Orleans, LA, 2Children's Hospital of Michigan, Detroit, MI, 3Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA, 4Nationwide Children's Hospital, Columbus, OH, 5Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY, 6Medical University of South Carolina, Charleston, SC

    *Purpose: Little is known about how pathology findings on biopsy correlate with outcomes in pediatric kidney transplant patients with antibody mediated rejection (AMR). We aimed…
  • 2020 American Transplant Congress

    Liver Transplantation for Primary Liver Sarcoma in Children-The US Experience from the Scientific Registry for Transplant Recipients (1988-2018)

    A. Amin, K. Soltys, S. Ranganathan, G. Bond, A. Khanna, A. Ganoza, Q. Sun, G. Mazariegos, R. Sindhi

    University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: Primary liver sarcomas (PLS) are rare tumors and encompass subtypes with diverse histology and varying outcomes. These subtypes include embryonal sarcoma (ES), rhabdomyosarcoma (RMS),…
  • 2020 American Transplant Congress

    Adult Split Liver Transplants Increased after Implementation of a Pediatric Liver Transplant Program

    J. Cullen1, P. Vargas1, S. Pelletier1, K. Soltys2, S. Rasmussen1, G. Mazariegos2, J. Oberholzer1, N. Goldaracena1

    1Surgery, University of Virginia, Charlottesville, VA, 2Surgery, University of Pittsburgh, Pittsburgh, PA

    *Purpose: Split liver transplantation (SLT) is a strategy to address organ shortage, but is technically more demanding than whole liver transplants.*Methods: SLTs conducted at a…
  • 2020 American Transplant Congress

    Limited Differences in Infectious Complications of Pediatric Liver Transplant between Hepatoblastoma and Non-Hepatoblastoma Patients

    H. Hendricks, A. Lane, J. Geller, A. Bondoc, A. Taylor, G. Paulsen, S. Hirth, S. Blum, G. Tiao, L. Danziger-Isakov

    Cincinnati Children's Hosp Med Cntr, Cincinnati, OH

    *Purpose: Pediatric liver transplantation (pLTX) has become a part of treatment for Hepatoblastoma (HB). The incidence and characterization of infectious events (IE) has not been…
  • 2020 American Transplant Congress

    Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens

    K. Le, A. Patel, N. M. Jasiak-Panek

    Pharmacy, Ann and Robert H. Lurie Children's Hospital, Chicago, IL

    *Purpose: Valganciclovir (VGCV) is FDA-approved for CMV prophylaxis in children aged one month to sixteen years old using the Pescovitz algorithm (7 x body surface…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 64
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences